Harrow, Inc. (HROW)
38.23
-0.82
(-2.10%)
USD |
NASDAQ |
May 08, 16:00
38.50
+0.27
(+0.71%)
After-Hours: 20:00
Harrow EPS Diluted (Quarterly) : 0.178 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.255 |
| Esperion Therapeutics, Inc. | -0.1002 |
| Theravance Biopharma, Inc. | -0.0962 |
| Xeris Biopharma Holdings, Inc. | 0.0126 |
| Aquestive Therapeutics, Inc. | -0.2612 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 6.626M |
| Revenue (Quarterly) | 89.09M |
| Total Expenses (Quarterly) | 82.47M |
| Enterprise Value | 1.602B |
| Gross Profit Margin (Quarterly) | 79.27% |
| Profit Margin (Quarterly) | 7.44% |
| Earnings Yield | -0.43% |
| Operating Earnings Yield | 2.70% |
| Normalized Earnings Yield | 0.3529 |